Search Results

5026 - 5050 of 104465
TitleWireDateTime
Lithium Ionic Files Statement of Defence, Crossclaim, Counterclaim and Third-Party Claim in Emerita Resources Litigation Globe Newswire 11/05 07:00
HydroGraph to Showcase Graphene-Carbon Black Hybrid for Cost-Effective Conductive Compounds at AMI Plastics World Expo Globe Newswire 11/05 07:00
Charming Medical Limited Announces Receipt of Nasdaq Delisting Determination Notice. Globe Newswire 11/05 07:00
Xunlei Limited Schedules 2026 Unaudited Third Quarter Earnings Release on November 12, 2026 Globe Newswire 11/05 07:00
INVE Technologies Sets Third Quarter 2026 Earnings Call for Thursday, November 12, 2026, at 5:00 PM EST Globe Newswire 11/05 07:00
Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition Globe Newswire 11/05 07:00
EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 Globe Newswire 11/05 07:00
C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 11/05 07:00
Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Globe Newswire 11/05 07:00
Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates Globe Newswire 11/05 07:00
GPGI Reports Third Quarter 2026 Results Globe Newswire 11/05 07:00
Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO) Globe Newswire 11/05 07:00
Astec Reports Third Quarter 2026 Results Globe Newswire 11/05 07:00
Monte Rosa Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates Globe Newswire 11/05 07:00
Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update  Globe Newswire 11/05 07:00
Entrada Therapeutics Reports Third Quarter 2026 Financial Results Globe Newswire 11/05 07:00
Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 11/05 07:00
Perma-Fix Reports Third Quarter 2026 Results, with Sequential Growth of 39% in Revenue and 25% in Treatment Backlog from Second Quarter 2026 Globe Newswire 11/05 07:00
Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin Globe Newswire 11/05 07:00
Weight Watchers Announces Third Quarter 2026 Results Globe Newswire 11/05 07:00
Commerce Announces Third Quarter 2026 Financial Results Globe Newswire 11/05 07:00
illumin Reports Third Quarter 2026 Financial Results Globe Newswire 11/05 07:00
Beamr Featured in The Wall Street Transcript; Expects Approximately 50% Revenue Growth in 2026 Globe Newswire 11/05 07:00
Apyx Medical Corporation Reports Third Quarter 2026 Financial Results Globe Newswire 11/05 07:00
Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases Globe Newswire 11/05 07:00
5026 - 5050 of 104465

News, Photo and Web Search

Search News by Ticker